SCHEMBL3374452

SCHEMBL3374452

CC(C)(C)NC(=O)c1c(OS(C)(=O)=O)cccc1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 4/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPK1 P28482 2/20 0.40
ALDH1A1 P00352 2/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
KCNA5 P22460 1/20 0.37
HSD17B10 Q99714 2/20 0.37
FABP3 P05413 1/20 0.36
FABP4 P15090 1/20 0.36
FABP5 Q01469 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ESR1 P03372 1/20 0.36
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3374458 0.89 MEN1 (0.44) ALOX15KMT2AMEN1MAPTHPGD
SCHEMBL550826 0.87 NPSR1 (0.52) ALOX15KMT2AMEN1MAPTHPGD
SCHEMBL3377816 0.87 KMT2A (0.39) ALOX15KMT2AMEN1MAPTHPGD
SCHEMBL3377686 0.87 NPSR1 (0.40) ALOX15KMT2AMEN1MAPTHPGD
SCHEMBL28769407 0.85 NPSR1 (0.39) ALOX15KMT2AMEN1MAPTHPGD
SCHEMBL2891984 0.84 NPSR1 (0.39) ALOX15KMT2AMEN1HPGDKDM4E
SCHEMBL11775342 0.82 CA12 (0.47) ALOX15KMT2AMAPTHPGDKDM4E
SCHEMBL551924 0.82 HPGD (0.41) KMT2AMAPTHPGDKDM4EMAPK1
SCHEMBL3377281 0.79 CA12 (0.43) KMT2AMEN1KDM4EMAPK1ALDH1A1
SCHEMBL3377862 0.78 POLB (0.45) KMT2AMEN1HPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 ALOX15 4156/4885KMT2A 102/4885MEN1 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.